Vimarsana
Biggest News Aggregation in the World

Page 7 - Divi Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Divi Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Divi Lab Today - Breaking & Trending Today

Business News | Stock Market Opens on a Downturn Amid Global Uncertainties - Vimarsana News

Business News | Stock Market Opens on a Downturn Amid Global Uncertainties

Get latest articles and stories on Business at LatestLY. The market dynamics indicated a challenging start, with a notable number of companies registering declines. In the Nifty index, only five companies showed advances, while a significant 45 companies faced declines. Business News | Stock Market Opens on a Downturn Amid Global Uncertainties.

Mid-day Mood | Indices recover from early losses amid gains in financial stocks, IT sees profit-booking - Vimarsana News

Mid-day Mood | Indices recover from early losses amid gains in financial stocks, IT sees profit-booking

The benchmark indices shrugged off weak global trend to recoup early losses to trade marginally high on gains in financial names

Mid-day Mood: Trade remains lacklustre on weak global cues ahead of Q3 earnings show - Vimarsana News

Mid-day Mood: Trade remains lacklustre on weak global cues ahead of Q3 earnings show

Investors remain on a 'wait-and-watch' mode ahead of the start of the Q3 earnings season which is likely to provide fresh cues for market directions.

Analyst Call Tracker: Banks, infra dominate Dec 'buy' lists; Bajaj Finance in top bets of 2023 - Vimarsana News

Analyst Call Tracker: Banks, infra dominate Dec 'buy' lists; Bajaj Finance in top bets of 2023

IT and pharma stocks wallowed in the pessimism list amid global and domestic headwinds, as per Moneycontrol’s Analyst Call Tracker for December.

nifty: Nifty to head towards 22-23K in a couple of months; 2 pharma stocks to buy: Mileen Vasudeo - Vimarsana News

nifty: Nifty to head towards 22-23K in a couple of months; 2 pharma stocks to buy: Mileen Vasudeo

Mileen Vasudeo says: “I am recommending two stocks here. One is Zydus Life which last time I had seen at Rs 730. Keep a stop loss of Rs 685, target would be Rs 769-797 levels. The second stock is by Divis Lab, currently trading at Rs 5,922. One can keep a stop loss of Rs 5,800 on the higher side. Yes, Rs 6,114-6,240 could be possible.”